Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2024 Category: Pharmaceuticals Source Type: news
Gestational Diabetes May Double Chronic Kidney Disease Risk Gestational Diabetes May Double Chronic Kidney Disease Risk
Gestational diabetes raises the risk for future chronic kidney disease, a risk heightened by subsequent diabetes or hypertension, found an analysis of Danish registry data.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 15, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Statin Initiation Cuts Mortality in Older Adults With Chronic Kidney Disease
FRIDAY, Jan. 5, 2024 -- Statin initiation may lower the risk for mortality and major adverse cardiovascular events (MACE) in older adults with chronic kidney disease (CKD) and no prior atherosclerotic cardiovascular disease (ASCVD), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 5, 2024 Category: Pharmaceuticals Source Type: news
For the Sake of Your Kidneys, Think Twice About Reaching for the Salt Shaker
(MedPage Today) -- Adding salt to food, even just sometimes, was significantly associated with a higher risk for chronic kidney disease (CKD), a large prospective cohort study showed.
In U.K. Biobank participants, those who said they always added... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 29, 2023 Category: Urology & Nephrology Source Type: news
What to Know About Heart Failure When You Have Diabetes
In June of 2022, a report from the American Diabetes Association highlighted heart failure as “an underappreciated complication of diabetes.” According to that report, up to 22% of people with diabetes will develop heart failure, and the incidence of heart failure within the diabetes community is increasing.
“Heart failure is the most prevalent cardiovascular complication in people with diabetes,” says Dr. Rodica Pop-Busui, a professor of diabetes at the University of Michigan and president of medicine and science at the American Diabetes Association. “In the U.S. alone there are 37 million...
Source: TIME: Health - December 29, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news
Frequency of Adding Salt to Foods Linked to Higher Risk for CKD
THURSDAY, Dec. 28, 2023 -- A higher self-reported frequency of adding salt to foods is associated with a higher risk for chronic kidney disease (CKD) in the general population, according to a study published online Dec. 28 in JAMA Network Open.Rui... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2023 Category: Pharmaceuticals Source Type: news
Residential structural racism and prevalence of chronic health conditions - Mohottige D, Davenport CA, Bhavsar N, Schappe T, Lyn MJ, Maxson P, Johnson F, Planey AM, McElroy LM, Wang V, Cabacungan AN, Ephraim P, Lantos P, Peskoe S, Lunyera J, Bentley-Edwards K, Diamantidis CJ, Reich B, Boulware LE.
IMPORTANCE: Studies elucidating determinants of residential neighborhood-level health inequities are needed. OBJECTIVE: To quantify associations of structural racism indicators with neighborhood prevalence of chronic kidney disease (CKD), diabetes,... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. MLYS, a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone, today announced that the…#radnor #launchhtnnct06153693 #joncongleton #mineralys #launchhtn #phase3 #advancehtn #transformhtn #ckd #pennsylvania (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2023 Category: Consumer Health News Source Type: news
Heart Failure Causally Linked to Chronic Kidney Disease
TUESDAY, Dec. 19, 2023 -- Heart failure is causally associated with chronic kidney disease (CKD), according to a study published online Dec. 11 in PLOS ONE.
Junyu Zhang, from Hunan University of Chinese Medicine in Changsha, China, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 19, 2023 Category: Pharmaceuticals Source Type: news
Outsize benefit seen in trial of drug for kidney disease
In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria - albumin in urine, a sign of kidney damage - for 50% of participants. When the experimental drug was paired with a standard-care medication, 70% of participants reportedly experienced a significant reduction in albuminuria. (Source: World Pharma News)
Source: World Pharma News - December 18, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Kids Who Are Overweight at Risk for Chronic Kidney Disease Kids Who Are Overweight at Risk for Chronic Kidney Disease
An increased risk for early CKD is observed even among adolescents with high-normal BMI and without diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 12, 2023 Category: Endocrinology Tags: Nephrology Source Type: news
Guideline Updated for Managing Hepatitis C in Chronic Kidney Disease
TUESDAY, Dec. 12, 2023 -- The Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease has been updated, according to a report... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2023 Category: Pharmaceuticals Source Type: news
High BMI in Adolescence Linked to Early CKD in Young Adulthood
MONDAY, Dec. 11, 2023 -- High body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news
Report: Kidney Disease Evident in These Eye Issues Report: Kidney Disease Evident in These Eye Issues
An analysis of four new studies found that retinal and choroidal thickness in the back of the eye correlates with kidney function in patients with chronic kidney disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 11, 2023 Category: Endocrinology Tags: Ophthalmology Source Type: news
Teens' High BMI Tied to Early Chronic Kidney Disease
(MedPage Today) -- High body mass index (BMI) at ages 16 to 20 was associated with chronic kidney disease (CKD) in early adulthood, a large cohort study showed.
Adjusted hazard ratios for CKD before age 45 ranged from 1.8 to 9.4 across BMI classes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 11, 2023 Category: Endocrinology Source Type: news
